Alliqua BioMedical
Pam Unger currently serves as the VP of Health Policy and Market Access at Alliqua BioMedical, Inc., a position held since June 2015. Prior to this role, Pam Unger was the VP of Medical Affairs and Clinical Education at Celleration, Inc., where responsibilities extended from September 2006 to May 2015. With extensive experience in health policy and medical affairs, Pam Unger has contributed significantly to the fields of medical education and clinical access.
This person is not in any teams
This person is not in any offices
Alliqua BioMedical
Alliqua BioMedical (NASDAQ: ALQA) is a functional regeneration company, building a suite of technological solutions that allow clinicians to utilize the latest advances in regenerative therapies to bring improved patient outcomes to their practices.